How Tafamidis and RNA Therapies Are Changing the ATTR-CM Landscape

a adăugat un sunet Health

2025-06-17 12:26:56

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a progressive, often underdiagnosed form of restrictive cardiomyopathy caused by the deposition of misfolded transthyretin (TTR) protein in the myocardium. Affecting both genetic and aging populations, ATTR-CM has emerged as a critical and increasingly recognized cause of heart failure with preserved ejection fraction (HFpEF), particularly in...

0 Commentarii 0 Distribuiri 45 Views 0 previzualizare